Effects of Tirzepatide on the Clinical and Symptom Burden of Patients with Heart Failure and a Preserved Ejection Fraction, Results from the SUMMIT Trial

被引:0
|
作者
Zile, Michael [1 ]
机构
[1] Med Univ South Carolina, Charleston, SC USA
关键词
Heart failure; adult; Disease management; Obesity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4171291
引用
收藏
页码:E746 / E746
页数:1
相关论文
共 50 条
  • [41] HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION - PUMPING HEART FAILURE?
    Sokolov, A. A.
    Martsinkevich, G., I
    KARDIOLOGIYA, 2018, 58 (06) : 79 - 84
  • [42] Prognostic impact of abnormal sodium burden in heart failure patients with preserved ejection fraction
    Zhen, Zhe
    Choy, Manting
    Dong, Bin
    Dong, Yugang
    Liang, Weihao
    Liu, Chen
    Xue, Ruicong
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (02)
  • [43] BURDEN OF HOSPITALISATIONS/READMISSIONS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION - A LITERATURE REVIEW
    Gogna, S.
    Agrawal, R.
    Jindal, R.
    Proudfoot, C.
    VALUE IN HEALTH, 2019, 22 : S543 - S543
  • [44] Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
    Edelmann, Frank
    Holzendorf, Volker
    Wachter, Rolf
    Nolte, Kathleen
    Schmidt, Albrecht G.
    Kraigher-Krainer, Elisabeth
    Duvinage, Andre
    Unkelbach, Ines
    Duengen, Hans-Dirk
    Tschoepe, Carsten
    Herrmann-Lingen, Christoph
    Halle, Martin
    Hasenfuss, Gerd
    Gelbrich, Goetz
    Stough, Wendy Gattis
    Pieske, Burkert M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (02) : 214 - 223
  • [45] Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction - EMPEROR-Preserved trial
    Boehm, M.
    Anker, S. D.
    Mahfoud, F.
    Filippatos, G.
    Ferreira, J. P.
    Pocock, S. J.
    Brueckmann, M.
    Linetzky, B.
    Schueler, E.
    Wanner, C.
    Zannad, F.
    Packer, M.
    Butler, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 983 - 983
  • [46] The Emperor-Preserved trial: what will change for patients with heart failure with preserved ejection fraction?
    Deaton, Christi
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (04) : 293 - 294
  • [47] Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Shahzeb Khan, Muhammad
    Pedro Ferreira, Joao
    Bocchi, Edimar
    Bohm, Michael
    Pieter Brunner-La Rocca, Hans
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio, V
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Seronde, Marie-France
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2383 - 2392
  • [48] Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry
    Seo, Masahiro
    Watanabe, Tetsuya
    Yamada, Takahisa
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Tamaki, Shunsuke
    Yasumura, Yoshio
    Sotomi, Yohei
    Hikoso, Shungo
    Nakatani, Daisaku
    Fukunami, Masatake
    Sakata, Yasushi
    CIRCULATION-HEART FAILURE, 2022, 15 (10) : E009789
  • [49] Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
    Kristensen, Soren L.
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Preiss, David
    Win, Sithu
    Kober, Lars
    McKelvie, Robert S.
    Zile, Michael R.
    Anand, Inder S.
    Komajda, Michel
    Gottdiener, John S.
    Carson, Peter E.
    McMurray, John J. V.
    CIRCULATION, 2017, 135 (08) : 724 - +
  • [50] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307